EXTON, Pa., Sept. 9 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at three investor conferences in September.
Joseph W. Kaufmann, Kensey Nash’s President & CEO, will deliver the Company’s presentation, at the following two conferences in New York City:
- Wednesday, September 15th, 2010 beginning at approximately 9:00 a.m. (ET) at the CL King’s Best Ideas Conference 2010 at the Omni Berkshire Place Hotel. To hear the live webcast of the Kensey Nash presentation, go to http://www.wsw.com/webcast/clk8/knsy/. The webcast will be archived for ninety days following the live presentation. The presentation materials will also be available on the company’s website (www.kenseynash.com) beginning at 9:00 a.m. (ET) on Wednesday, September 15th, 2010.
- Wednesday, September 22nd, 2010 beginning at approximately at 2:00 p.m. (ET) at the UBS Global Life Sciences Conference at the Grand Hyatt New York. To hear the live webcast of the Kensey Nash presentation, go to http://cc.talkpoint.com/ubsx001/092110a_lv/?entity=111_18F2UB4. The presentation materials will also be available on the company’s website (www.kenseynash.com) beginning at 2:00 p.m. (ET) on Wednesday, September 22nd, 2010.
Michael Celano, Kensey Nash’s Chief Financial Officer, will deliver the Company’s presentation at the JMP Securities Healthcare Conference at The New York Palace Hotel on Monday, September 27th, 2010 at 1:30 p.m. To hear the live webcast of the Kensey Nash presentation, go to http://www.wsw.com/webcast/jmp11/knsy/. The webcast will be archived for ninety days following the live presentation. The presentation materials will also be available on the company’s website (www.kenseynash.com) beginning at 1:30 p.m. (ET) on Monday, September 27th, 2010.
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including, the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.
SOURCE Kensey Nash Corporation
